Risk of cancer after assisted reproduction: A review of the available evidences and guidance to fertility counselors

L. Del Pup, F. A. Peccatori, P. E. Levi-Setti, G. Codacci-Pisanelli, P. Patrizio

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: Infertile women requiring ovarian stimulation and assisted reproduction techniques (ART) are faced with difficult issues. The fear that using hormones could increase their risk of cancer is the most significant. One of the main challenges for assessing cancer risk after ART is the difficulty to separate it from the underlying condition of infertility per se. The delay or the inability to achieve a pregnancy is an important risk factor for breast, endometrial and ovarian cancer. We analyzed the current literature on the topic. MATERIALS AND METHODS: The published literature in Medline and Cochrane was screened using the following keywords: ovulation induction, reproductive techniques, clomiphene, in vitro fertilization, fertility agents, female/adverse effects, female/toxicity gonadotropins/adverse effects or gonadotropins/toxicity and "neoplasms or cancer". RESULTS: A total of 95 articles were evaluated. Limited evidence suggests that high doses or many cycles of clomiphene citrate could increase the risk of endometrial cancer, although the confounding factors of polycystic ovarian disease and overweight are not always considered. In some studies, ART modestly increased the risk of borderline ovarian cancer. Fertility treatments do not increase the risk of breast, cervical, endometrial and ovarian cancers, thyroid, melanoma and colon cancer. CONCLUSIONS: Women can be reassured that fertility drugs do not appear to significantly increase the risk of invasive ovarian, endometrial, breast or other cancers, while achieving a pregnancy at an earlier age is a significant protective factor.

Original languageEnglish
Pages (from-to)8042-8059
Number of pages18
JournalEuropean Review for Medical and Pharmacological Sciences
Volume22
Issue number22
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Reproductive Techniques
Reproduction
Fertility
Endometrial Neoplasms
Ovarian Neoplasms
Neoplasms
Clomiphene
Ovulation Induction
Female Fertility Agents
Gonadotropins
Thyroid Neoplasms
Colonic Neoplasms
Fertility Agents
Ovarian Diseases
Breast Neoplasms
Pregnancy
Fertilization in Vitro
Uterine Cervical Neoplasms
Infertility
Fear

Keywords

  • Breast cancer
  • Cancer risk
  • Colon cancer
  • Fertility drugs
  • Gynecological cancer
  • In-vitro fertilization
  • Melanoma
  • Ovarian cancer
  • Ovarian stimulation
  • Thyroid cancer

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Risk of cancer after assisted reproduction : A review of the available evidences and guidance to fertility counselors. / Del Pup, L.; Peccatori, F. A.; Levi-Setti, P. E.; Codacci-Pisanelli, G.; Patrizio, P.

In: European Review for Medical and Pharmacological Sciences, Vol. 22, No. 22, 01.01.2018, p. 8042-8059.

Research output: Contribution to journalArticle

@article{08562e33a64e4007a6023c66d699dbc0,
title = "Risk of cancer after assisted reproduction: A review of the available evidences and guidance to fertility counselors",
abstract = "OBJECTIVE: Infertile women requiring ovarian stimulation and assisted reproduction techniques (ART) are faced with difficult issues. The fear that using hormones could increase their risk of cancer is the most significant. One of the main challenges for assessing cancer risk after ART is the difficulty to separate it from the underlying condition of infertility per se. The delay or the inability to achieve a pregnancy is an important risk factor for breast, endometrial and ovarian cancer. We analyzed the current literature on the topic. MATERIALS AND METHODS: The published literature in Medline and Cochrane was screened using the following keywords: ovulation induction, reproductive techniques, clomiphene, in vitro fertilization, fertility agents, female/adverse effects, female/toxicity gonadotropins/adverse effects or gonadotropins/toxicity and {"}neoplasms or cancer{"}. RESULTS: A total of 95 articles were evaluated. Limited evidence suggests that high doses or many cycles of clomiphene citrate could increase the risk of endometrial cancer, although the confounding factors of polycystic ovarian disease and overweight are not always considered. In some studies, ART modestly increased the risk of borderline ovarian cancer. Fertility treatments do not increase the risk of breast, cervical, endometrial and ovarian cancers, thyroid, melanoma and colon cancer. CONCLUSIONS: Women can be reassured that fertility drugs do not appear to significantly increase the risk of invasive ovarian, endometrial, breast or other cancers, while achieving a pregnancy at an earlier age is a significant protective factor.",
keywords = "Breast cancer, Cancer risk, Colon cancer, Fertility drugs, Gynecological cancer, In-vitro fertilization, Melanoma, Ovarian cancer, Ovarian stimulation, Thyroid cancer",
author = "{Del Pup}, L. and Peccatori, {F. A.} and Levi-Setti, {P. E.} and G. Codacci-Pisanelli and P. Patrizio",
year = "2018",
month = "1",
day = "1",
doi = "10.26355/eurrev-201811-16434",
language = "English",
volume = "22",
pages = "8042--8059",
journal = "European Review for Medical and Pharmacological Sciences",
issn = "1128-3602",
publisher = "Verduci Editore",
number = "22",

}

TY - JOUR

T1 - Risk of cancer after assisted reproduction

T2 - A review of the available evidences and guidance to fertility counselors

AU - Del Pup, L.

AU - Peccatori, F. A.

AU - Levi-Setti, P. E.

AU - Codacci-Pisanelli, G.

AU - Patrizio, P.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - OBJECTIVE: Infertile women requiring ovarian stimulation and assisted reproduction techniques (ART) are faced with difficult issues. The fear that using hormones could increase their risk of cancer is the most significant. One of the main challenges for assessing cancer risk after ART is the difficulty to separate it from the underlying condition of infertility per se. The delay or the inability to achieve a pregnancy is an important risk factor for breast, endometrial and ovarian cancer. We analyzed the current literature on the topic. MATERIALS AND METHODS: The published literature in Medline and Cochrane was screened using the following keywords: ovulation induction, reproductive techniques, clomiphene, in vitro fertilization, fertility agents, female/adverse effects, female/toxicity gonadotropins/adverse effects or gonadotropins/toxicity and "neoplasms or cancer". RESULTS: A total of 95 articles were evaluated. Limited evidence suggests that high doses or many cycles of clomiphene citrate could increase the risk of endometrial cancer, although the confounding factors of polycystic ovarian disease and overweight are not always considered. In some studies, ART modestly increased the risk of borderline ovarian cancer. Fertility treatments do not increase the risk of breast, cervical, endometrial and ovarian cancers, thyroid, melanoma and colon cancer. CONCLUSIONS: Women can be reassured that fertility drugs do not appear to significantly increase the risk of invasive ovarian, endometrial, breast or other cancers, while achieving a pregnancy at an earlier age is a significant protective factor.

AB - OBJECTIVE: Infertile women requiring ovarian stimulation and assisted reproduction techniques (ART) are faced with difficult issues. The fear that using hormones could increase their risk of cancer is the most significant. One of the main challenges for assessing cancer risk after ART is the difficulty to separate it from the underlying condition of infertility per se. The delay or the inability to achieve a pregnancy is an important risk factor for breast, endometrial and ovarian cancer. We analyzed the current literature on the topic. MATERIALS AND METHODS: The published literature in Medline and Cochrane was screened using the following keywords: ovulation induction, reproductive techniques, clomiphene, in vitro fertilization, fertility agents, female/adverse effects, female/toxicity gonadotropins/adverse effects or gonadotropins/toxicity and "neoplasms or cancer". RESULTS: A total of 95 articles were evaluated. Limited evidence suggests that high doses or many cycles of clomiphene citrate could increase the risk of endometrial cancer, although the confounding factors of polycystic ovarian disease and overweight are not always considered. In some studies, ART modestly increased the risk of borderline ovarian cancer. Fertility treatments do not increase the risk of breast, cervical, endometrial and ovarian cancers, thyroid, melanoma and colon cancer. CONCLUSIONS: Women can be reassured that fertility drugs do not appear to significantly increase the risk of invasive ovarian, endometrial, breast or other cancers, while achieving a pregnancy at an earlier age is a significant protective factor.

KW - Breast cancer

KW - Cancer risk

KW - Colon cancer

KW - Fertility drugs

KW - Gynecological cancer

KW - In-vitro fertilization

KW - Melanoma

KW - Ovarian cancer

KW - Ovarian stimulation

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=85057741888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057741888&partnerID=8YFLogxK

U2 - 10.26355/eurrev-201811-16434

DO - 10.26355/eurrev-201811-16434

M3 - Article

VL - 22

SP - 8042

EP - 8059

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

SN - 1128-3602

IS - 22

ER -